Showing results (1371-1380 of 1,612) with videos related to

Sort By:
Pageof 162
Haematologica|May 4, 2019
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemiaAllan Beke, Lucie Laplane, Julie Riviere, et al.
Nature Biotechnology|December 15, 2010
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cellsEirini P Papapetrou, Gabsang Lee, Nirav Malani, et al.
Scandinavian Journal of Immunology|November 20, 2016
The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic SclerosisF Tall, M Dechomet, S Riviere, et al.
Circulation|May 14, 2003
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cellsChristine Mummery, Dorien Ward-van Oostwaard, Pieter Doevendans, et al.
Journal of Robotic Surgery|January 13, 2024
Outcomes of lateral approach in robot-assisted radical prostatectomy: insights from a single-surgeon experienceCarlo Giulioni, Daniele Castellani, Nam-Son Vuong, et al.
World Neurosurgery|February 13, 2026
Functional outcomes after resection of middle frontal gyrus versus superior frontal gyrus tumorsAndrea R Hsu, Ali Gharibi Loron, Yooree Ha, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumorsNicolas André, Marie Cécile Le Deley, Clémence Léguillette, et al.
Investigative Ophthalmology & Visual Science|October 28, 2003
Proteome analysis of lens epithelia, fibers, and the HLE B-3 cell lineShuh-Tuan Wang-Su, Ashley L McCormack, Shaojun Yang, et al.
Molecular Cancer Therapeutics|August 5, 2020
High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse CancersPaul Riviere, Aaron M Goodman, Ryosuke Okamura, et al.
Platelets|May 2, 2023
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched studyArthur Mageau, Bernard Bonnotte, Mikael Ebbo, et al.
Pageof 162